Which of the following is true about depression:
First, I need to recall common MCQs related to depression. Common topics include diagnosis criteria, treatment options, side effects of medications, or subtypes. Let's think about typical correct answers. For example, the DSM-5 criteria for major depressive disorder, the role of serotonin and norepinephrine in pathophysiology, or the use of SSRIs as first-line treatment.
If the correct answer is about SSRIs, then the options might be different classes of antidepressants. Let's say the options are: A. Tricyclics are first-line, B. SNRIs are contraindicated, C. SSRIs are first-line, D. MAOIs are first-line. Then the correct answer would be C.
Now, constructing the explanation. The core concept would be the pharmacological treatment of depression. The correct answer's explanation would discuss SSRIs as first-line due to their efficacy and safety. The wrong options would be incorrect because tricyclics have more side effects, SNRIs are actually used but not contraindicated, MAOIs are less commonly first-line due to dietary restrictions.
Clinical pearl could be remembering SSRIs as first-line, maybe with a mnemonic like S for Safe and Simple. Then end with the correct answer line.
Need to make sure all sections are included and formatted correctly. Also, check character count to stay within limits. Let me put it all together now.
**Core Concept**
Depression, particularly Major Depressive Disorder (MDD), is characterized by persistent low mood and anhedonia, with pathophysiology involving dysregulation of monoamine neurotransmitters (serotonin, norepinephrine, dopamine). First-line treatment focuses on restoring neurotransmitter balance with minimal side effects.
**Why the Correct Answer is Right**
Selective serotonin reuptake inhibitors (SSRIs) are first-line therapies for MDD due to their favorable side effect profile and efficacy. They inhibit serotonin reuptake, increasing synaptic serotonin levels. Common SSRIs include fluoxetine, sertraline, and escitalopram. Their mechanism avoids the anticholinergic and cardiovascular side effects of tricyclic antidepressants (TCAs), making them safer for most patients.
**Why Each Wrong Option is Incorrect**
**Option A:** "Tricyclic antidepressants (TCAs) are first-line" is incorrect because TCAs (e.g., amitriptyline) are now second-line due to significant side effects like sedation, dry mouth, and cardiac toxicity.
**Option B:** "SNRIs are contraindicated in depression" is incorrect; serotonin-norepinephrine reuptake inhibitors (SNRIs) like venlafaxine are valid second-line agents for MDD.
**Option D:** "MAOIs are first-line for most patients" is incorrect; monoamine oxidase inhibitors (MAOIs) are reserved for treatment-resistant cases due to dietary restrictions and potential hypertensive crises.
**Clinical Pearl / High-Yield Fact**
Remember the mnemonic **"SSRIs: Safe, Simple,